A Blank Rome team represented Quoin Pharmaceuticals Ltd., a late clinical-stage specialty pharmaceutical company focused on rare and orphan diseases, in its securities purchase agreement with institutional investors.

Read the full press release: Blank Rome Represents Quoin Pharmaceuticals in Connection with Private Placement Financing